US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Related articles
Iran's nuclear policy unlikely to change even after president's death
DUBAI, United Arab Emirates (AP) — While Iran’s nuclear program stands at the precipice of tipping o2024-05-22Chongqing Youth Film Project unites global youth
The launching ceremony of this year's Looking China - Youth Film Project was held on Friday at S2024-05-22Committee advances bill to let Alabama inmates speak at parole hearings
MONTGOMERY, Ala. (AP) — A legislative committee on Thursday advanced a bill to allow state inmates,2024-05-22- ATHENS, Greece (AP) — The head of Greece’s extreme far-right Golden Dawn party was granted condition2024-05-22
Mississippi woman pleads guilty to stealing government funds
JACKSON, Miss. (AP) — A Mississippi woman has pleaded guilty in federal court to illegally taking un2024-05-22ReelFocus Project selects fresh blood for film industry's future
A short film section of the 14th Beijing International Film Festival (BJIFF), held on April 19, hope2024-05-22
atest comment